Literature DB >> 31525497

7T quantitative magnetization transfer (qMT) of cortical gray matter in multiple sclerosis correlates with cognitive impairment.

Lydia J McKeithan1, Bailey D Lyttle2, Bailey A Box2, Kristin P O'Grady2, Richard D Dortch3, Benjamin N Conrad4, Lindsey M Thompson5, Baxter P Rogers2, Paul Newhouse6, Siddharama Pawate7, Francesca Bagnato7, Seth A Smith8.   

Abstract

Cognitive impairment (CI) is a major manifestation of multiple sclerosis (MS) and is responsible for extensively hindering patient quality of life. Cortical gray matter (cGM) damage is a significant contributor to CI, but is poorly characterized by conventional MRI let alone with quantitative MRI, such as quantitative magnetization transfer (qMT). Here we employed high-resolution qMT at 7T via the selective inversion recovery (SIR) method, which provides tissue-specific indices of tissue macromolecular content, such as the pool size ratio (PSR) and the rate of MT exchange (kmf). These indices could represent expected demyelination that occurs in the presence of gray matter damage. We utilized selective inversion recovery (SIR) qMT which provides a low SAR estimate of macromolecular-bulk water interactions using a tailored, B1 and B0 robust inversion recovery (IR) sequence acquired at multiple inversion times (TI) at 7T and fit to a two-pool model of magnetization exchange. Using this sequence, we evaluated qMT indices across relapsing-remitting multiple sclerosis patients (N = 19) and healthy volunteers (N = 37) and derived related associations with neuropsychological measures of cognitive impairment. We found a significant reduction in kmf in cGM of MS patients (15.5%, p = 0.002), unique association with EDSS (ρ = -0.922, p = 0.0001), and strong correlation with cognitive performance (ρ = -0.602, p = 0.0082). Together these findings indicate that the rate of MT exchange (kmf) may be a significant biomarker of cGM damage relating to CI in MS.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31525497     DOI: 10.1016/j.neuroimage.2019.116190

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  7 in total

Review 1.  Quantitative magnetization transfer imaging in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.

Authors:  Elizabeth N York; Michael J Thrippleton; Rozanna Meijboom; David P J Hunt; Adam D Waldman
Journal:  Brain Commun       Date:  2022-04-04

Review 2.  Macromolecular Proton Fraction as a Myelin Biomarker: Principles, Validation, and Applications.

Authors:  Alena A Kisel; Anna V Naumova; Vasily L Yarnykh
Journal:  Front Neurosci       Date:  2022-02-09       Impact factor: 5.152

3.  Relaxation-Compensated Chemical Exchange Saturation Transfer MRI in the Brain at 7T: Application in Relapsing-Remitting Multiple Sclerosis.

Authors:  Kristin P O'Grady; Sanjana Satish; Quinn R Owen; Bailey A Box; Francesca Bagnato; Anna J E Combes; Sarah R Cook; Holly James Westervelt; Haley R Feiler; Richard D Lawless; Asha Sarma; Shekinah D Malone; Josephine M Ndolo; Keejin Yoon; Richard D Dortch; Baxter P Rogers; Seth A Smith
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.003

4.  An in vivo implementation of the MEX MRI for myelin fraction of mice brain.

Authors:  Ella Wilczynski; Efrat Sasson; Uzi Eliav; Gil Navon; Uri Nevo
Journal:  MAGMA       Date:  2021-08-06       Impact factor: 2.310

5.  In vivo tensor-valued diffusion MRI of focal demyelination in white and deep grey matter of rodents.

Authors:  Yi He; Susana Aznar; Hartwig R Siebner; Tim B Dyrby
Journal:  Neuroimage Clin       Date:  2021-04-15       Impact factor: 4.881

Review 6.  Recent advances in understanding multiple sclerosis.

Authors:  Peter K Stys; Shigeki Tsutsui
Journal:  F1000Res       Date:  2019-12-13

Review 7.  Neuroimaging Correlates of Cognitive Dysfunction in Adults with Multiple Sclerosis.

Authors:  Maria Petracca; Giuseppe Pontillo; Marcello Moccia; Antonio Carotenuto; Sirio Cocozza; Roberta Lanzillo; Arturo Brunetti; Vincenzo Brescia Morra
Journal:  Brain Sci       Date:  2021-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.